RAGGI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 2.574
AS - Asia 2.173
EU - Europa 1.939
SA - Sud America 353
AF - Africa 30
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.097
Nazione #
US - Stati Uniti d'America 2.545
RU - Federazione Russa 964
CN - Cina 657
SG - Singapore 630
HK - Hong Kong 291
BR - Brasile 282
IT - Italia 281
KR - Corea 267
IE - Irlanda 169
PL - Polonia 147
SE - Svezia 130
VN - Vietnam 115
IN - India 75
DE - Germania 64
FI - Finlandia 43
AR - Argentina 34
GB - Regno Unito 34
ID - Indonesia 31
FR - Francia 28
AU - Australia 26
JO - Giordania 21
EC - Ecuador 17
NL - Olanda 16
CA - Canada 12
MK - Macedonia 10
UA - Ucraina 10
ZA - Sudafrica 10
IQ - Iraq 9
JP - Giappone 9
TW - Taiwan 9
AT - Austria 8
BD - Bangladesh 8
CH - Svizzera 8
TR - Turchia 8
IR - Iran 7
CI - Costa d'Avorio 6
MX - Messico 6
CO - Colombia 5
ES - Italia 5
KZ - Kazakistan 5
LK - Sri Lanka 5
PH - Filippine 5
AZ - Azerbaigian 4
BJ - Benin 4
PK - Pakistan 4
TH - Thailandia 4
BO - Bolivia 3
CL - Cile 3
EE - Estonia 3
EG - Egitto 3
KE - Kenya 3
PE - Perù 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
HU - Ungheria 2
JM - Giamaica 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
NI - Nicaragua 2
PA - Panama 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BW - Botswana 1
GP - Guadalupe 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.097
Città #
Santa Clara 1.027
Singapore 484
Hefei 285
Ashburn 268
Seoul 265
Hong Kong 243
Dublin 168
Warsaw 147
Fairfield 116
Chandler 86
Florence 84
Beijing 77
Altamura 62
Lawrence 62
Los Angeles 58
Moscow 57
Houston 51
Seattle 50
Kent 48
Buffalo 46
Cambridge 39
Wilmington 38
Ho Chi Minh City 37
Woodbridge 37
Princeton 32
Boston 29
Melbourne 26
Dallas 24
Hanoi 24
Munich 24
Mumbai 23
São Paulo 22
Jakarta 20
Shanghai 20
Bengaluru 19
Milan 18
San Diego 18
Ann Arbor 17
Rome 16
Turku 16
West Jordan 16
The Dalles 15
Helsinki 14
New York 13
Lappeenranta 12
Paris 12
Chicago 11
Falkenstein 11
Dong Ket 10
Frankfurt am Main 10
London 9
Atlanta 8
Belo Horizonte 8
Guayaquil 8
Medford 8
Rio de Janeiro 8
Tokyo 8
Abidjan 6
Boardman 6
Curitiba 6
Modena 6
Phoenix 6
Quito 6
Clifton 5
Colombo 5
Hangzhou 5
Istanbul 5
Pune 5
Baku 4
Bern 4
Biella 4
Brasília 4
Cisano Bergamasco 4
Cotonou 4
Fortaleza 4
Haiphong 4
Hillsboro 4
Isidro Casanova 4
Kolkata 4
Lấp Vò 4
Montreal 4
Poços de Caldas 4
San Francisco 4
Zurich 4
Amsterdam 3
Andover 3
Baghdad 3
Berlin 3
Brooklyn 3
Cairo 3
Chandigarh 3
Chennai 3
Columbus 3
Falls Church 3
Guangzhou 3
Hyderabad 3
Johannesburg 3
Marseille 3
Naples 3
New Taipei City 3
Totale 4.537
Nome #
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 261
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 207
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 177
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 176
Fatty acids regulate the biology of cholangiocarcinoma cells 175
The role of stroma in cholangiocarcinoma: The intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium 174
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 170
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease 167
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 165
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 164
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 161
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators 153
Organoids and spheroids: advanced in vitro models for liver cancer research. 150
Role of chemokines in the biology of cholangiocarcinoma 149
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features 142
DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives 138
Establishment and characterization of a new spontaneously immortalized ER-/PR-/HER2+ human breast cancer cell line, DHSF-BR16 137
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 134
The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion 129
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 126
Metabolic reprogramming in cholangiocarcinoma 123
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 121
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. 119
3D Modeling: Insights into the Metabolic Reprogramming of Cholangiocarcinoma Cells 118
Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells 116
The role of the hedgehog pathway in cholangiocarcinoma 115
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma 114
A novel multidrug‐resistant cell line from an italian intrahepatic cholangiocarcinoma patient 110
Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma 109
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2 106
Epigenetic reprogramming modulates malignant properties of human liver cancer 106
Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer 104
An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer. 103
Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic Cholangiocarcinoma 103
RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines 101
Assessment of a high sensitivity method for identification of IDH1 R132x mutations in tumors and plasma of Intrahepatic Cholangiocarcinoma patients 101
Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line resistant to gemcitabine 97
Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. 96
Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma 96
Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity 96
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus. 95
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 95
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages 95
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types 95
Mesenchymal stem cells, aging and regenerative medicine. 92
Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the beta-cell line INS-1E. 92
More than shots in the dark: improving patient stratification to move closer to personalised therapies in intrahepatic cholangiocarcinoma 91
Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the β-cell line INS-1E 90
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts 89
Plasma membrane γ-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells 89
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance 88
Iron metabolism in liver cancer stem cells 87
Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells 85
Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. 85
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma 85
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 83
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma 83
Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma 82
Methylation and liver cancer 73
Mapping the landscape of biliary tract cancer in Europe: challenges and controversies 60
The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma 35
A novel naphthoquinone compound triggers DNA damage-induced apoptosis on cholangiocarcinoma through upregulation of BAX 25
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcome 13
Totale 7.216
Categoria #
all - tutte 21.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 23 20 17 35 36 21 23
2021/2022258 27 2 3 8 4 15 1 17 63 15 28 75
2022/2023613 62 166 51 16 14 105 84 37 52 4 12 10
2023/2024422 11 30 41 30 31 40 19 101 16 35 60 8
2024/20252.970 69 277 145 430 878 352 135 77 156 81 138 232
2025/20262.375 411 566 545 456 347 50 0 0 0 0 0 0
Totale 7.216